CKX10 Antibody

What is Cytokeratin 10 (CK10) and what is its significance in experimental research?

Cytokeratin 10 (CK10), also known as KRT10, is an important structural protein predominantly found in the suprabasal layers of the epidermis. It plays a critical role in maintaining the integrity and function of the skin barrier . CK10 belongs to the intermediate filament family of proteins that form part of the cytoskeleton in epithelial cells.

From a research perspective, CK10 is significant because:

• It serves as a differentiation marker for stratified squamous epithelia

• It contributes to maintaining cell layer development and keratin filament bundles in suprabasal cells

• It has been implicated in microbial interactions, including mediating S. aureus adherence to desquamated nasal epithelial cells and S. pneumoniae binding to lung cell lines

• Its abnormal expression patterns are associated with various pathological conditions, particularly in epithelial tissues

What are the common applications of CK10 antibodies in laboratory research?

CK10 antibodies are versatile research tools with several validated applications:

Each application requires specific optimization parameters, including antibody dilution, incubation time, and antigen retrieval methods.

How should researchers select between monoclonal and polyclonal CK10 antibodies?

The choice between monoclonal and polyclonal CK10 antibodies depends on the specific research objectives:

Monoclonal CK10 Antibodies:

• Offer high specificity for a single epitope (e.g., clone DE-K10)

• Provide consistent lot-to-lot reproducibility

• Typically demonstrate lower background staining

• Ideal for specific applications requiring high precision

• Examples: Mouse monoclonal anti-CK10 antibody (clone DE-K10) reacts with human and dog samples

Polyclonal CK10 Antibodies:

• Recognize multiple epitopes on the CK10 antigen

• Often provide higher sensitivity due to binding multiple sites

• May show greater batch-to-batch variation

• Useful when the protein conformation might be altered by experimental conditions

• Examples: Rabbit polyclonal antibodies against human or rat CK10

Selection criteria should include the target species, application type, and whether epitope accessibility might be compromised during sample processing.

What positive and negative controls should be used when working with CK10 antibodies?

Proper controls are essential for validating CK10 antibody performance:

Positive Controls:

• Skin sections with stratified squamous epithelium (most commonly used)

• Skin sections with adnexal structures (hair follicles, sebaceous and sweat glands)

• Keratinizing epidermal cells from dog skin for cross-species validation

• Cell lines known to express CK10 (e.g., certain epithelial cell lines)

Negative Controls:

• Omission of primary antibody while following standard staining procedure

• Tissues known not to express CK10 (e.g., certain internal organs)

• Cell lines with CK10 knockdown or knockout (e.g., siRNA-treated HCT 116 cells)

• Isotype controls to assess non-specific binding

The use of both positive and negative controls is critical for distinguishing true signal from background and ensuring the validity of experimental results.

What are the recommended validation approaches for CK10 antibodies in research applications?

Comprehensive validation of CK10 antibodies is essential for ensuring experimental reproducibility. The International Working Group for Antibody Validation proposes five validation "pillars" :

• Genetic Strategy:

  • Use of CK10 knockout or knockdown models (e.g., siRNA-treated cell lines)

  • Comparison of staining in wild-type versus CK10-deficient samples

• Orthogonal Strategy:

  • Correlation of protein expression using non-antibody-based methods (e.g., mass spectrometry)

  • Verification with RT-qPCR to correlate protein detection with mRNA levels

• Independent Antibody Strategy:

  • Comparison of staining patterns using multiple antibodies targeting different CK10 epitopes

  • Concordance between different clones (e.g., DE-K10 and others) strengthens validity

• Expression of Tagged Proteins:

  • Use of epitope-tagged CK10 constructs for verification

  • Comparison of antibody detection with tag-specific antibodies

• Immunocapture-Mass Spectrometry:

  • Verification that immunoprecipitated protein is indeed CK10 through MS analysis

  • Confirmation of specificity in complex protein mixtures

For robust validation, researchers should implement at least one of these strategies, with the orthogonal and independent antibody approaches being most common in practice .

What are the optimal antigen retrieval methods for CK10 detection in immunohistochemistry?

Antigen retrieval (AR) is crucial for successful CK10 detection in formalin-fixed tissues due to epitope masking . Optimization depends on fixation conditions and antibody characteristics:

Heat-Induced Epitope Retrieval (HIER):

• Most commonly used for CK10 detection

• Citrate buffer (pH 6.0) or EDTA buffer (pH 9.0) can be effective

• Pressure cooker methods (121°C for 3-5 minutes) often yield optimal results

• Microwave heating (95-98°C for 10-20 minutes) represents an alternative approach

Enzymatic Digestion Methods:

• Proteinase K or trypsin digestion can sometimes improve CK10 detection

• Generally less effective than HIER for CK10

• May be used as a complementary approach in difficult cases

Combined Approaches:

• Sequential application of HIER followed by mild enzymatic digestion

• Particularly useful for heavily fixed or archived specimens

Optimization should include testing multiple AR conditions with appropriate positive controls. Researchers should document that slides remain wet throughout the entire protocol after deparaffinization to prevent drying artifacts .

How can researchers troubleshoot weak or absent CK10 antibody staining?

When faced with weak or absent CK10 staining, a systematic troubleshooting approach is recommended:

Additionally, for fluorescence-based detection:

• Verify that illumination and detection parameters match the fluorophore excitation/emission profile

• Check that antibody has not been exposed to light for extended periods

• Consider signal amplification methods for low-abundance targets

What is the significance of CK10 expression alterations in cancer research?

CK10 expression changes have emerging significance in cancer research, particularly in:

Hepatocellular Carcinoma (HCC):

• CK10 expression in hepatoma cells can be 11.7-fold higher than in normal liver cells

• May serve as a tumor-associated antigen and potential therapeutic target

• Could be involved in HCC formation and development processes

Laryngeal Squamous Cell Carcinoma:

• CK10 has diagnostic utility in differentiating between benign laryngeal lesions, dysplasia, and squamous cell carcinoma

• Expression patterns change during malignant transformation

Other Epithelial Cancers:

• Altered CK10 expression may indicate changes in cellular differentiation state

• Can serve as a biomarker in combination with other cytokeratins

Research approaches include:

• Comparative analysis of CK10 expression in tumor vs. normal adjacent tissue

• Correlation of expression levels with clinical outcomes

• Functional studies of CK10's role in cancer cell properties (migration, invasion, etc.)

• Evaluation as a potential tumor-associated antigen for immunotherapeutic targeting

How can CK10 antibodies be integrated into multiplex immunofluorescence panels?

Incorporating CK10 antibodies into multiplex immunofluorescence (mIF) panels requires careful consideration of several factors:

Antibody Validation for Multiplexing:

• Each antibody in the panel must be thoroughly optimized and validated individually before multiplexing

• Testing on tissue microarrays (TMAs) containing different tissues and cancer types is recommended

• At least one validation pillar should be applied (genetic, orthogonal, independent antibody strategies)

Panel Design Considerations:

• Antibody species compatibility to avoid cross-reactivity

• Fluorophore selection based on spectral characteristics and target abundance

• CK10 is often paired with other differentiation markers or structural proteins

Technical Optimization:

• Determine the optimal antibody sequence in sequential staining approaches

• Validate that CK10 signal is not affected by multiplexing procedures

• Establish appropriate controls for each marker in the panel

Analysis Approaches:

• Quantitative assessment of co-localization patterns

• Spatial relationship analysis between CK10 and other markers

• Correlation of expression patterns with biological or clinical parameters

When implementing mIF panels, researchers should document all optimization steps and validation results to ensure reproducibility and meaningful interpretation of results.

What methodological considerations are important when using CK10 antibodies across different experimental models?

When applying CK10 antibodies across different experimental models, researchers should consider:

Species Reactivity:

• Confirm antibody cross-reactivity with the target species

• Human-reactive CK10 antibodies may work with canine, feline, and rat samples, but validation is essential

• Consider species-specific antibodies when cross-reactivity is limited

Cell/Tissue Type Specificity:

• Different epithelial tissues may express varying levels of CK10

• Suprabasal layers of epidermis show strongest expression

• Expression in non-cutaneous epithelia may require more sensitive detection methods

Fixation and Processing Variables:

• Formaldehyde fixation affects epitope accessibility differently across models

• Optimize fixation time for each experimental system (typically 24-48 hours)

• Consider model-specific antigen retrieval optimization

Experimental Context:

• In vitro models may show different CK10 expression patterns than in vivo systems

• 3D culture systems often better recapitulate physiological CK10 expression

• Patient-derived xenografts require consideration of both human and host species reactivity

Quantification Approaches:

• Standardize image acquisition parameters across different models

• Develop model-specific scoring systems when appropriate

• Consider automated analysis tools calibrated for each experimental system

Thorough documentation of all methodological variables is essential for reproducibility and valid cross-model comparisons.